Nanoengineered biomaterials for advanced drug delivery / (Record no. 82453)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05316cam a2200637 a 4500 |
001 - CONTROL NUMBER | |
control field | on1159162541 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20230516165856.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr un|---aucuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200620s2020 ne o 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | EBLCP |
Language of cataloging | eng |
Description conventions | pn |
Transcribing agency | EBLCP |
Modifying agency | YDX |
-- | OPELS |
-- | UKAHL |
-- | OCLCF |
-- | UKMGB |
-- | N$T |
-- | OCLCQ |
-- | OCLCO |
-- | K6U |
-- | OCLCQ |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
National bibliography number | GBC075827 |
Source | bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
Record control number | 019819556 |
Source | Uk |
019 ## - | |
-- | 1159206835 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0081029861 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780081029862 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780081029855 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 0081029853 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)1159162541 |
Canceled/invalid control number | (OCoLC)1159206835 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | R857.M3 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 610.28 |
Edition number | 23 |
245 00 - TITLE STATEMENT | |
Title | Nanoengineered biomaterials for advanced drug delivery / |
Statement of responsibility, etc. | edited by Masoud Mozafari. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Amsterdam : |
Name of publisher, distributor, etc. | Elsevier, |
Date of publication, distribution, etc. | 2020. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (826 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
490 1# - SERIES STATEMENT | |
Series statement | Woodhead Publishing Series in Biomaterials |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Print version record. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Intro -- Nanoengineered Biomaterials for Advanced Drug Delivery -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgment -- Part One Principles of nanotechnology-based drug delivery -- 1 Principles of nanosized drug delivery systems -- 1.1 Introduction -- 1.2 What are nanosized drug delivery systems and why they are useful? -- 1.3 Different types of nanodelivery systems -- 1.3.1 Polymeric nanoparticles -- 1.3.2 Liposomes -- 1.3.3 Niosomes -- 1.3.4 Solid lipid nanoparticles -- 1.3.5 Micro- and nanoemulsions -- 1.3.6 Polymeric micelles -- 1.3.7 Dendrimers |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 1.3.8 Inorganic nanoparticles and quantum dots -- 1.3.9 Nanocrystals -- 1.3.10 Protein-based and natural biopolymer-based nanoparticles -- 1.4 Particle properties and related biobarrier interactions of nanosystems -- 1.4.1 Opsonization and phagocytosis -- 1.4.2 Particle size -- 1.4.3 Shape -- 1.4.4 Surface charge -- 1.4.5 Hydrophilic/hydrophobic character -- 1.4.6 Other factors -- 1.5 Nanoparticles in medicines -- 1.5.1 Lipid nanotechnology -- 1.5.2 Nanoparticle nanotechnology -- 1.6 Conclusions -- References -- 2 Controlled/localized release and nanotechnology -- 2.1 Introduction |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 2.2 The evolution of drug delivery systems -- 2.3 Nanostructures from dimension viewpoint -- 2.3.1 Zero-dimensional nanostructures -- 2.3.2 One-dimensional nanostructures -- 2.3.3 Two-dimensional nanostructures -- 2.3.4 Three-dimensional nanostructures -- 2.4 Bionanostructures -- 2.5 Micro- and nanomotors -- 2.6 Conclusion -- References -- 3 Stimuli-sensitive drug delivery systems -- 3.1 Introduction -- 3.2 pH-sensitive drug delivery systems -- 3.3 Redox-sensitive drug delivery systems -- 3.4 Thermosensitive drug delivery systems -- 3.5 Magnetically sensitive drug delivery systems |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 3.6 Ultrasound-sensitive drug delivery systems -- 3.7 Photosensitive drug delivery systems -- 3.8 Electrosensitive drug delivery systems -- 3.8.1 Intrinsically conducting polymers -- 3.8.2 Hydrogels -- 3.9 Enzyme-sensitive drug delivery systems -- 3.10 Dual- and multisensitive drug delivery systems -- 3.11 Conclusions -- References -- 4 Sustainable drug delivery systems through green nanotechnology -- 4.1 Nanotechnology -- 4.2 Green nanotechnology -- 4.3 Green nanotechnology in drug delivery -- 4.4 Classification of nanoparticles -- 4.4.1 Liposomes -- 4.4.2 Polymeric nanoparticles |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 4.4.3 Dendrimer -- 4.4.4 Quantum dots -- 4.4.5 Silica nanoparticles -- 4.4.6 Magnetic nanoparticles -- 4.5 Metal-organic frameworks -- 4.6 Green methods for synthesis of MOFs -- 4.6.1 Mechanochemistry -- 4.6.2 Sonochemistry -- 4.6.3 Microwave -- 4.7 Synthesis of MOFs by using bioactive molecules -- 4.8 Summary -- References -- Further reading -- 5 Recent advances in multifunctional nanoengineered biomaterials -- 5.1 Introduction -- 5.2 Recent advances in imaging techniques -- 5.2.1 Optical imaging -- 5.2.2 Photoacoustic imaging -- 5.2.3 Multimodality imaging |
500 ## - GENERAL NOTE | |
General note | 5.3 Recent advances in biomedical applications |
500 ## - GENERAL NOTE | |
General note | Includes index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanostructured materials. |
9 (RLIN) | 4537 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomedical materials. |
9 (RLIN) | 3868 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug delivery systems. |
9 (RLIN) | 7290 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanostructures |
Authority record control number or standard number | (DNLM)D049329 |
9 (RLIN) | 5928 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biocompatible Materials |
Authority record control number or standard number | (DNLM)D001672 |
9 (RLIN) | 5921 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomedical and Dental Materials |
Authority record control number or standard number | (DNLM)D001697 |
9 (RLIN) | 68432 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Delivery Systems |
Authority record control number or standard number | (DNLM)D016503 |
9 (RLIN) | 7290 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanomat�eriaux. |
Authority record control number or standard number | (CaQQLa)201-0258061 |
9 (RLIN) | 68453 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomat�eriaux. |
Authority record control number or standard number | (CaQQLa)201-0025723 |
9 (RLIN) | 68433 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Syst�emes d'administration de m�edicaments. |
Authority record control number or standard number | (CaQQLa)000260397 |
9 (RLIN) | 68784 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomedical materials. |
Source of heading or term | fast |
Authority record control number or standard number | (OCoLC)fst00832586 |
9 (RLIN) | 3868 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug delivery systems. |
Source of heading or term | fast |
Authority record control number or standard number | (OCoLC)fst00898667 |
9 (RLIN) | 7290 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nanostructured materials. |
Source of heading or term | fast |
Authority record control number or standard number | (OCoLC)fst01032630 |
9 (RLIN) | 4537 |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mozafari, Masoud. |
9 (RLIN) | 68785 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Mozafari, Masoud. |
Title | Nanoengineered Biomaterials for Advanced Drug Delivery. |
Place, publisher, and date of publication | San Diego : Elsevier, �2020 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Woodhead Publishing series in biomaterials. |
9 (RLIN) | 68481 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | <a href="https://www.sciencedirect.com/science/book/9780081029855">https://www.sciencedirect.com/science/book/9780081029855</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | eBooks |
No items available.